Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.34 +0.25%
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q1 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $38.6 million versus the consensus estimate of $37.71 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2022 revenue of $185-195 million, versus the consensus of $189.4 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Loop Capital Starts Chime Financial (CHYM) at Buy
- GameStop (GME) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
